Yan Li

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 7

Top Topics

African American

Clinical Evaluation

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical pharmacology

Oncology and therapy

Pediatric research

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ken Ogasawara, Nastya Kassir, Xiaomin Wang, Bouchra Benettaib, Simon Zhou, Maria Palmisano, Yan Li
Recurrent or progressive pediatric brain tumors: population pharmacokinetics and exposure-response analysis of pomalidomide. Pediatric research 90 (4) (2021)
Ken Ogasawara, Kathryn Newhall, Stephen E Maxwell, Justine Dell'Aringa, Vitalina Komashko, Nurgul Kilavuz, Richard Delarue, Myron Czuczman, Lars Sternas, Shelonitda Rose, C L Beach, Steven Novick, Simon Zhou, Maria Palmisano, Yan Li
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies. Clinical pharmacokinetics 59 (2) (2021)
Yan Li, Nastya Kassir, Xiaomin Wang, Maria Palmisano, Simon Zhou
Population Pharmacokinetics and Exposure Response Analysis of Pomalidomide in Subjects With Relapsed or Refractory Multiple Myeloma From the Novel Combination Treatment of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone. Journal of clinical pharmacology 60 (8) (2020)
Ken Ogasawara, Simon Zhou, Gopal Krishna, Maria Palmisano, Yan Li
Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia. Cancer chemotherapy and pharmacology 84 (4) (2019)
Ken Ogasawara, Kimberly MacGorman, Liangang Liu, Jian Chen, Leonidas N Carayannopoulos, Simon Zhou, Maria Palmisano, Yan Li
Drug-Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC-122) in Healthy Adult Subjects. Journal of clinical pharmacology 59 (12) (2019)
Xiaomin Wang, Jian Chen, Josephine Reyes, Simon Zhou, Maria Palmisano, Yan Li
A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach. Oncology and therapy 8 (1) (2019)
Yan Li, Liangang Liu, Diana Gomez, Jian Chen, Zeen Tong, Maria Palmisano, Simon Zhou
Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects. Pharmacology research & perspectives 6 (6) (2018)